ozempic glp 1 mechanism of action of GLP-1 [25] Semaglutide (Wegovy®)
Description
Weight loss is never guaranteed, and individual results vary
![ozempic glp 1 mechanism of action of GLP-1 [25] Semaglutide (Wegovy)](https://www.straighthealthcare.com/image/glp-1-therapies.png)
M.AgarwalS.ChangD
![ozempic glp 1 mechanism of action of GLP-1 [25] Semaglutide (Wegovy)](https://images.squarespace-cdn.com/content/v1/623b264bc7cbc7255854872e/85e3a2dc-a91e-40ad-a062-feaf27ce7d88/Screen+Shot+2024-04-18+at+11.50.05+PM.png)
'Retatrutide (LY3437943), a novel triple glucagon, guanidine-dependent insulinotropic polypeptide, and glucagon-like peptide-1 receptor agonist.' The Lancet
![ozempic glp 1 mechanism of action of GLP-1 [25] Semaglutide (Wegovy)](https://www.novomedlink.com/diabetes/products/treatments/ozempic/about/how-ozempic-works/_jcr_content/root/slab_1406248137_copy/content/accordion_copy/item_1773938863640/image.img.png/1778156789054/ozempic-pill-snac.png)
In SURMOUNT-1, approximately 4.3-7.1% of participants discontinued due to side effects (dose-dependent), compared to 6.4% with liraglutide in the SCALE trials
![ozempic glp 1 mechanism of action of GLP-1 [25] Semaglutide (Wegovy)](https://journals.library.columbia.edu/public/site/images/mmd2262/chen-spp.png)
Does the type of surgery change GLP-1 guidance
![ozempic glp 1 mechanism of action of GLP-1 [25] Semaglutide (Wegovy)](https://www.amjmed.com/cms/asset/3229fc1b-34b3-4be6-8fab-b5e0f64772c1/gr1.jpg)